Given the positive results of LEADER, can you speculate on the likely mechanisms that explain the CV risk reduction that was observed?

Given the positive results of LEADER, can you speculate on the likely mechanisms that explain the CV risk reduction that was observed?

Given the positive results of LEADER, can you speculate on the likely mechanisms that explain the CV risk reduction that was observed?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Lawrence Leiter, MD, FRCP(C), FACP

Lawrence Leiter, MD, FRCP(C), FACP

Head, Division of Endocrinology and Metabolism Director, Lipid Clinic Associate Director, Clinical Nutrition and Risk Factor Modification Centre St. Michael’s Hospital Professor of Medicine and Nutritional Sciences University of Toronto Toronto, Ontario